# Medtronic Faces Federal Antitrust Lawsuit Over Surgical Stapler Market Dominance Lexington Medical alleges Medtronic uses exclusionary bundling to block competition in surgical stapling. - **Source:** [Courthouse News](https://www.courthousenews.com) - **Published:** 2026-11-06 - **Topic:** [Business](https://brifing.si/c/business) - **Original article:** - **On Brifing:** https://brifing.si/s/926c2772-4024-4af8-953e-ff292ba41512 ## Antitrust Lawsuit Filed Lexington Medical has initiated a 63-page federal antitrust lawsuit against Medtronic in Boston. The plaintiff accuses the medical device giant of engaging in illegal monopolistic practices to suppress competition. Lexington claims Medtronic maintains over 90% market share in laparoscopic staplers by preventing hospitals from conducting trials of rival medical products. ## Allegations of Market Exclusion The lawsuit alleges that Medtronic utilizes restrictive agreements to lock hospitals into long-term portfolios. Lexington claims these contracts force clients to purchase multiple product categories, including monopolar and bipolar devices, to receive discounts. This bundling strategy allegedly makes it impossible for smaller competitors to close deals or gain market entry. ## Internal Documents Cited Lexington cites internal documents purportedly showing Medtronic instructed its sales force to report any hospital attempting competitor trials. One document allegedly describes a strategy to eliminate competition by preventing rivals from getting a window for product testing. These records are central to the claim that Medtronic actively thwarts market innovation. ## Clinical Superiority Claims Lexington argues its AEON Endoscopic Stapling System is clinically superior to Medtronic’s offerings. According to the filing, one head-to-head hospital trial rated the AEON stapler as better in 89% of cases. Lexington contends that it would win on merit if Medtronic did not prevent fair competition through its predatory contractual agreements. ## History of Legal Challenges This case follows a previous federal antitrust loss for Medtronic involving Applied Medical Resources Corp. Earlier this year, a jury ordered Medtronic to pay $382 million for unlawfully bundling its LigaSure device. That case established a precedent for the current allegations regarding how Medtronic protects its market share through portfolio-wide mechanisms. ## Executive Statements Highlighted The lawsuit points to statements from Medtronic executives to illustrate the company's restrictive approach. CEO Geoff Martha noted in 2025 that the company has very tight contracts tested over time. Additionally, a regional vice-president reportedly boasted that customers were locked down for years, further supporting claims of intentional market foreclosure. ## Legal Demands and Scope Lexington is suing under the Sherman Act and Massachusetts antitrust law. The company seeks unspecified damages and a permanent court order to enjoin Medtronic from entering into exclusionary and predatory agreements. The lawsuit aims to dismantle the barriers that currently prevent hospitals from choosing alternative, potentially more innovative surgical stapling technologies. ## Broader Market Implications The outcome of this litigation could significantly impact how large medical device manufacturers structure hospital contracts. If the court rules against Medtronic, it may force a shift toward more open competition in the surgical equipment sector. Hospitals currently locked into long-term agreements may gain more flexibility to adopt superior, cost-effective medical technologies. ## Sources covering this story - https://www.courthousenews.com/medtronic-hit-with-antitrust-suit-over-surgical-staplers/ — --- _Summary written by Brifing from the original reporting. Copyright in the original article belongs to its publisher; read the full piece at the link above._